Eric P. Winer
Harvard University(US)Yale Cancer Center(US)Yale University(US)CancerCare(US)Dana-Farber Cancer Institute(US)Dana-Farber/Harvard Cancer Center(US)Dana-Farber Brigham Cancer Center(US)Smilow Cancer Hospital(US)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Advanced Breast Cancer Therapies, HER2/EGFR in Cancer Research, Cancer Treatment and Pharmacology, Cancer Genomics and Diagnostics
Most-Cited Works
- → Breast Cancer Treatment(2019)4,714 cited
- → Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer(2018)4,261 cited
- → Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013(2013)3,672 cited
- → 3rd ESO–ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 3)(2016)2,058 cited
- → Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer(2016)1,956 cited
- → American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer(2005)1,884 cited